Form D - Notice of Exempt Offering of Securities:
SEC Accession No. 0001632925-15-000001
Filing Date
2015-02-13
Accepted
2015-02-13 10:27:47
Documents
1
Effectiveness Date
2015-02-13
Items
Item 06b:
Item 3C: Investment Company Act Section 3(c)
Item 3C.7: Section 3(c)(7)

Document Format Files

Seq Description Document Type Size
1 primary_doc.html D  
1 primary_doc.xml D 5121
  Complete submission text file 0001632925-15-000001.txt   6309
Mailing Address 441 LEXINGTON AVENUE 9TH FLOOR NEW YORK NY 10017
Business Address 441 LEXINGTON AVENUE 9TH FLOOR NEW YORK NY 10017 646-214-7458
iCapital-OrbiMed Royalty Opportunities II Access Fund, L.P. (Filer) CIK: 0001632925 (see all company filings)

EIN.: 300833420 | State of Incorp.: DE | Fiscal Year End: 1231
Type: D | Act: 33 | File No.: 021-234053 | Film No.: 15610249